Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis

S Schlesinger, A Lang, N Christodoulou, P Linnerz… - Diabetologia, 2023 - Springer
Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Renin‐angiotensin aldosterone system inhibitors and COVID‐19: a systematic review and meta‐analysis revealing critical bias across a body of observational …

J Loader, FC Taylor, E Lampa… - Journal of the American …, 2022 - Am Heart Assoc
Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies,
observational in design, appear to use biased methods that can distort the interaction …

Characteristics of COVID-19 patients admitted to intensive care Unit in Multispecialty Hospital of Riyadh, Saudi Arabia: a retrospective study

M Almuqbil, AI Almoteer, AM Suwayyid, AH Bakarman… - Healthcare, 2023 - mdpi.com
During the early stages of the COVID-19 pandemic, infection rates were high and symptoms
were severe. Medical resources, including healthcare experts and hospital facilities, were …

Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations

Gunadi, MS Hakim, H Wibawa, Marcellus… - Scientific Reports, 2021 - nature.com
The outcome of SARS-CoV-2 infection is determined by multiple factors, including the viral,
host genetics, age, and comorbidities. This study investigated the association between …

Discontinuation of antihypertensive drug use compared to continuation in COVID-19 patients: a systematic review with meta-analysis and trial sequential analysis

D Chambergo-Michilot, FM Runzer-Colmenares… - High Blood Pressure & …, 2023 - Springer
Introduction COVID-19 related mortality is about 2%, and it increases with comorbidities, like
hypertension. Regarding management, there is debatable evidence about the benefits of …

[HTML][HTML] Risk factors and characteristics of hospitalized COVID-19 patients in Jordan

RO Alqaisi, WA Al-Kubaisy, SN Abughanam… - Saudi Medical …, 2023 - ncbi.nlm.nih.gov
Objectives: To investigate the occurrence and identify the factors contributing to
hospitalization among individuals diagnosed with COVID-19. Methods: From June 15, 2020 …

O uso de inibidores do sistema renina angiotensina aldosterona em pacientes hipertensos com COVID-19

MS Vieira, ALS Vieira, ACA Rezende… - Revista Eletrônica …, 2021 - acervomais.com.br
Objetivo: Destacar e revisar os principais aspectos relacionados à infecção pela Covid-19 e
a manutenção ou interrupção do tratamento de pacientes hipertensos em uso de Inibidores …

[HTML][HTML] Clinical Outcomes of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in COVID-19 Patients With Pre-existing Cardiac …

S Srinivasa, S Kaur, A Dharani, E Choi, A Kalidas… - Cureus, 2023 - ncbi.nlm.nih.gov
The growing research regarding the implementation of angiotensin-converting enzyme-2
inhibitors (ACEi) and angiotensin receptor blockers (ARBs) in the treatment of COVID-19 in …

Effect of ACE2 expression inhibiting drugs on COVID-19 disease severity, outcome and length of admission in Ethiopian patients: A causal inference using marginal …

TW Leulseged, IS Hassen, WC Zewde, EH Maru… - Ethiopian Medical …, 2022 - ajol.info
Background: There are varying and contradicting reports and in the face of lack of evidence
generated on the effect of ACE2 (Angiotensin-converting enzyme inhibitors) expression …

Investigating the interrelatedness of clinical and non-clinical parameters affecting outcomes in COVID-19 patients: a retrospective study

M Asim, A Rahatullah, K Wahid… - Pathogens and Global …, 2023 - Taylor & Francis
The COVID-19 pandemic has affected millions globally. Several studies have been carried
out to uncover factors affecting the severity of the resulting infection. Available location …